Evidence map›Paper›PMID 42397716›Full record

ArticleJournal of medicinal chemistry2026

Library Docking for Cannabinoid-2 Receptor Ligands.

Moira M Rachman, Christos Iliopoulos-Tsoutsouvas, Michael D Sacco, Xinyu Xu, Cheng-Guo Wu, Emma Santos, Isabella S Glenn, Lu Paris, Michelle K Cahill, Suthakar Ganapathy and 9 more

Abstract read
In one paragraph

Article in Journal of medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Moira M RachmanDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, United States.ORCID 0000-0003-3671-8885
Christos Iliopoulos-TsoutsouvasCenter for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts 02115, United States.ORCID 0000-0003-3750-431X
Michael D SaccoDepartment of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, California 94305, United States.ORCID 0000-0001-5930-7363
Xinyu XuDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, United States.
Cheng-Guo WuDepartment of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, California 94305, United States.
Emma SantosDepartment of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, California 94305, United States.
Isabella S GlennDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, United States.
Lu ParisDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, United States.
Michelle K CahillDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California 94305, United States.
Suthakar GanapathyCenter for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts 02115, United States.
Tia A TumminoDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, United States.ORCID 0000-0001-9155-820X
Yurii S MorozEnamine Ltd., Kyiv 02094, Ukraine.ORCID 0000-0001-6073-002X
Dmytro S RadchenkoEnamine Ltd., Kyiv 02094, Ukraine.ORCID 0000-0001-5444-7754
Meri OkorieDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, United States.
Vivianne L TawfikDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California 94305, United States.
John J IrwinDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, United States.ORCID 0000-0002-1195-6417
Alexandros MakriyannisCenter for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts 02115, United States.ORCID 0000-0003-3272-3687
Georgios SkiniotisDepartment of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, California 94305, United States.
Brian K ShoichetDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, United States.ORCID 0000-0002-6098-7367

Funding

Development and Testing of New Computational Methods for Ligand Discovery and MechanismR35GM122481 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Brian K Shoichet · 2017 to 2026
$8.5M
NIGMS NIH HHS R35 GM122481
6 · The paper itself

Abstract

Cannabinoid receptors are both therapeutically attractive and are interesting model systems for structure-based methods. Here we investigated topical questions in library docking using the CB2 receptor. While a CB1R docking campaign found potent but nonselective ligands, here subtype selective ligands were found by targeting polar residues. Hit rates and hit affinities improved with library size, but docking against active and inactive receptor states did not reliably bias toward agonists or antagonists. Cryo-EM structures of two of the new agonists superposed well on the docking predictions. Structure-based optimization led to 10- to 140-fold improvements within three series, consistent with well-behaved ligands. Hit rates with an explicit 2.6 billion molecule library resembled those of an implied 11 billion molecule library from a building-block method, supporting the latter's ability to explore this space, though higher affinities were discovered from the explicit set. Implications for future studies are considered.

Indexed as

Molecular Docking SimulationReceptor, Cannabinoid, CB2Small Molecule LibrariesAnimalsCryoelectron MicroscopyHumansLigandsReceptor, Cannabinoid, CB1Structure-Activity RelationshipLigandsReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Small Molecule Libraries

Identifiers

PMID42397716
PMCPMC13403315

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.